371 related articles for article (PubMed ID: 31168092)
1. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
Ardain A; Domingo-Gonzalez R; Das S; Kazer SW; Howard NC; Singh A; Ahmed M; Nhamoyebonde S; Rangel-Moreno J; Ogongo P; Lu L; Ramsuran D; de la Luz Garcia-Hernandez M; K Ulland T; Darby M; Park E; Karim F; Melocchi L; Madansein R; Dullabh KJ; Dunlap M; Marin-Agudelo N; Ebihara T; Ndung'u T; Kaushal D; Pym AS; Kolls JK; Steyn A; Zúñiga J; Horsnell W; Yokoyama WM; Shalek AK; Kløverpris HN; Colonna M; Leslie A; Khader SA
Nature; 2019 Jun; 570(7762):528-532. PubMed ID: 31168092
[TBL] [Abstract][Full Text] [Related]
2. Lung type 3 innate lymphoid cells respond early following
Das S; Chauhan KS; Ahmed M; Akter S; Lu L; Colonna M; Khader SA
mBio; 2024 Apr; 15(4):e0329923. PubMed ID: 38407132
[TBL] [Abstract][Full Text] [Related]
3. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity.
Khader SA; Rangel-Moreno J; Fountain JJ; Martino CA; Reiley WW; Pearl JE; Winslow GM; Woodland DL; Randall TD; Cooper AM
J Immunol; 2009 Dec; 183(12):8004-14. PubMed ID: 19933855
[TBL] [Abstract][Full Text] [Related]
4. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis.
Maglione PJ; Xu J; Chan J
J Immunol; 2007 Jun; 178(11):7222-34. PubMed ID: 17513771
[TBL] [Abstract][Full Text] [Related]
5. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
[TBL] [Abstract][Full Text] [Related]
6. CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.
Slight SR; Rangel-Moreno J; Gopal R; Lin Y; Fallert Junecko BA; Mehra S; Selman M; Becerril-Villanueva E; Baquera-Heredia J; Pavon L; Kaushal D; Reinhart TA; Randall TD; Khader SA
J Clin Invest; 2013 Feb; 123(2):712-26. PubMed ID: 23281399
[TBL] [Abstract][Full Text] [Related]
7. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.
Cohen SB; Gern BH; Delahaye JL; Adams KN; Plumlee CR; Winkler JK; Sherman DR; Gerner MY; Urdahl KB
Cell Host Microbe; 2018 Sep; 24(3):439-446.e4. PubMed ID: 30146391
[TBL] [Abstract][Full Text] [Related]
8. IL-22 produced by type 3 innate lymphoid cells (ILC3s) reduces the mortality of type 2 diabetes mellitus (T2DM) mice infected with Mycobacterium tuberculosis.
Tripathi D; Radhakrishnan RK; Sivangala Thandi R; Paidipally P; Devalraju KP; Neela VSK; McAllister MK; Samten B; Valluri VL; Vankayalapati R
PLoS Pathog; 2019 Dec; 15(12):e1008140. PubMed ID: 31809521
[TBL] [Abstract][Full Text] [Related]
9. Blocking IL-10 receptor signaling ameliorates Mycobacterium tuberculosis infection during influenza-induced exacerbation.
Ring S; Eggers L; Behrends J; Wutkowski A; Schwudke D; Kröger A; Hierweger AM; Hölscher C; Gabriel G; Schneider BE
JCI Insight; 2019 Apr; 5(10):. PubMed ID: 30998505
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis induces CCL18 expression in human macrophages.
Ferrara G; Bleck B; Richeldi L; Reibman J; Fabbri LM; Rom WN; Condos R
Scand J Immunol; 2008 Dec; 68(6):668-74. PubMed ID: 18959625
[TBL] [Abstract][Full Text] [Related]
11. Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice.
Montaldo E; Juelke K; Romagnani C
Eur J Immunol; 2015 Aug; 45(8):2171-82. PubMed ID: 26031799
[TBL] [Abstract][Full Text] [Related]
12. IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
Ronacher K; Sinha R; Cestari M
Front Immunol; 2018; 9():2209. PubMed ID: 30319650
[TBL] [Abstract][Full Text] [Related]
13. Chemokines in tuberculosis: the good, the bad and the ugly.
Monin L; Khader SA
Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis.
Gopal R; Rangel-Moreno J; Slight S; Lin Y; Nawar HF; Fallert Junecko BA; Reinhart TA; Kolls J; Randall TD; Connell TD; Khader SA
Mucosal Immunol; 2013 Sep; 6(5):972-84. PubMed ID: 23299616
[TBL] [Abstract][Full Text] [Related]
15. Modeling Granulomas in Response to Infection in the Lung.
Hao W; Schlesinger LS; Friedman A
PLoS One; 2016; 11(3):e0148738. PubMed ID: 26986986
[TBL] [Abstract][Full Text] [Related]
16. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.
Gopal R; Monin L; Slight S; Uche U; Blanchard E; Fallert Junecko BA; Ramos-Payan R; Stallings CL; Reinhart TA; Kolls JK; Kaushal D; Nagarajan U; Rangel-Moreno J; Khader SA
PLoS Pathog; 2014 May; 10(5):e1004099. PubMed ID: 24831696
[TBL] [Abstract][Full Text] [Related]
17. Host defense and recruitment of Foxp3⁺ T regulatory cells to the lungs in chronic Mycobacterium tuberculosis infection requires toll-like receptor 2.
McBride A; Konowich J; Salgame P
PLoS Pathog; 2013; 9(6):e1003397. PubMed ID: 23785280
[TBL] [Abstract][Full Text] [Related]
18. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung.
Khader SA; Guglani L; Rangel-Moreno J; Gopal R; Junecko BA; Fountain JJ; Martino C; Pearl JE; Tighe M; Lin YY; Slight S; Kolls JK; Reinhart TA; Randall TD; Cooper AM
J Immunol; 2011 Nov; 187(10):5402-7. PubMed ID: 22003199
[TBL] [Abstract][Full Text] [Related]
19. Innate lymphoid cells exhibited IL-17-expressing phenotype in active tuberculosis disease.
Pan L; Chen X; Liu X; Qiu W; Liu Y; Jiang W; Zheng Y; Mou Y; Xu W; Li X; Ge H; Zhu H
BMC Pulm Med; 2021 Oct; 21(1):318. PubMed ID: 34641843
[TBL] [Abstract][Full Text] [Related]
20. Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis.
Kim WS; Kim JS; Cha SB; Han SJ; Kim H; Kwon KW; Kim SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(12):e0145234. PubMed ID: 26675186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
